Articles liés à Acute Myelogenous Leukemia: Genetics, Biology and Therapy

Acute Myelogenous Leukemia: Genetics, Biology and Therapy - Couverture rigide

Livre 86 sur 180: Cancer Treatment and Research
 
9780387692579: Acute Myelogenous Leukemia: Genetics, Biology and Therapy
Couverture rigide
ISBN 10 : 0387692576 ISBN 13 : 9780387692579
Editeur : Springer-Verlag New York Inc., 2009

Synopsis

This volume contains a multitude of chapters from pioneers in the area of genetic mechanisms, targeted therapy, biology and mouse models for acute myelogenous leukemia. AML is the most common form of leukemia in adults. It is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered. This book adds much to the debate.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l'auteur

Lalitha Nagarajan is an Associate Professor, Department of Molecular Genetics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
Springer-Verlag New York Inc.
Date d'édition
2009
Langue
anglais
ISBN 10 
0387692576
ISBN 13 
9780387692579
Reliure
Relié
Nombre de pages
289
Éditeur
Nagarajan Lalitha
Coordonnées du fabricant
Springer Nature Customer Service Center GmbH
ProductSafety@springernature.com

Europaplatz 3
Heidelberg
69115
Allemagne